A detailed history of Black Rock Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 9,771,891 shares of IONS stock, worth $367 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,771,891
Previous 9,057,530 7.89%
Holding current value
$367 Million
Previous $458 Million 7.55%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$42.03 - $53.55 $30 Million - $38.3 Million
714,361 Added 7.89%
9,771,891 $424 Million
Q4 2023

Feb 13, 2024

SELL
$43.39 - $51.63 $2.48 Million - $2.95 Million
-57,097 Reduced 0.63%
9,057,530 $458 Million
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $829,559 - $1.02 Million
-21,547 Reduced 0.24%
9,114,627 $413 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $5.35 Million - $6.67 Million
153,928 Added 1.71%
9,136,174 $375 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $3.27 Million - $4.01 Million
-97,311 Reduced 1.07%
8,982,246 $321 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $5.33 Million - $6.68 Million
143,495 Added 1.61%
9,079,557 $343 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $3.82 Million - $5.09 Million
104,672 Added 1.19%
8,936,062 $395 Million
Q2 2022

Aug 12, 2022

BUY
$31.71 - $43.0 $12.3 Million - $16.7 Million
387,547 Added 4.59%
8,831,390 $327 Million
Q1 2022

May 12, 2022

SELL
$29.88 - $37.04 $2.85 Million - $3.54 Million
-95,439 Reduced 1.12%
8,443,843 $313 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $10.7 Million - $14.7 Million
419,429 Added 5.17%
8,539,282 $260 Million
Q3 2021

Nov 09, 2021

SELL
$33.54 - $40.55 $2.01 Million - $2.43 Million
-59,813 Reduced 0.73%
8,119,853 $272 Million
Q2 2021

Aug 11, 2021

BUY
$34.54 - $47.25 $283 Million - $386 Million
8,179,666 New
8,179,666 $326 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.33B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.